Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics for SSI prevention in endoscopic carpal tunnel release
NCT03432858Phase 4Completed
- Sponsor
- WellSpan Health
- Start
- May 2018
- Primary completion
- Dec 2020
- Modality
- Reversible Covalent Inhibitors, Cyclic Peptides, Antimicrobial Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vancomycin and cefazolin in surgical site infection (SSI) (3 arms), sponsored by WellSpan Health. Primary endpoint: Number of Participants With Surgical Site Infection. Started May 2018; status: completed.
02
Drugs
vancomycincefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03432858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432858.